Everolimus Tablet
Product Images NDC 72319-003

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 72319-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of the active ingredient everolimus, showing its molecular components and bonds in a two-dimensional formula representation.*

FDA Label Image

Everolimus-blister-pack-0-25-mg (Everolimus Blister Pack 0 25 mg)

Label for Everolimus Tablet 0.25 mg by i3 Pharmaceuticals, LLC. The label features repeated blocks displaying the product name, dosage strength, 'Rx Only', and manufacturer information from Warminster, PA. Each block includes a barcode and NDC 72319-003-10, with space for lot and expiration dates, and instructions to peel.*

FDA Label Image

Everolimus-blister-pack-0-5-mg (Everolimus Blister Pack 0 5 mg)

Label for Everolimus Tablet, 0.5 mg, an oral prescription drug manufactured and distributed by i3 Pharmaceuticals, LLC, Warminster, PA. The label includes the NDC number 72319-015-10, a barcode, and spaces for lot and expiration information. The text and barcode repeat multiple times on the sheet for packaging purposes.*

FDA Label Image

Everolimus-blister-pack-0-75-mg (Everolimus Blister Pack 0 75 mg)

Everolimus Tablet 0.75 mg oral tablet blister packaging label from i3 Pharmaceuticals, LLC. The label shows the NDC number 72319-016-10, with repeated sections for multiple tablets. Each section includes the proprietary name Everolimus Tablet, strength 0.75 mg, Rx Only designation, manufacturer and distributor information (i3 Pharmaceuticals, LLC, Warminster, PA), barcode, and placeholders for lot and expiration dates.*

FDA Label Image

Everolimus-blister-pack-1-mg (Everolimus Blister Pack 1 mg)

A multi-dose blister card label for Everolimus Tablet, 1 mg, manufactured and distributed by i3 Pharmaceuticals, LLC, Warminster, PA 18974. Each section includes the NDC number 72319-017-10, dosage strength, barcode, and space for lot and expiration date information. The packaging indicates Rx only status and features peel here markers at the center.*

FDA Label Image

Everolimus-carton-0-25-mg (Everolimus Carton 0 25 mg)

Everolimus Tablets 0.25 mg per tablet packaging label, NDC 72319-003-60, featuring prominently the product name and strength in a white and blue color scheme. The label specifies that the package contains 6 blister cards with 10 tablets each. It includes the labeler name i3 Pharmaceuticals, LLC, and states 'Rx Only' with dispensing instructions and storage conditions. A barcode and QR code are visible on the packaging.*

FDA Label Image

Everolimus-carton-0-5-mg (Everolimus Carton 0 5 mg)

Everolimus Tablets 0.5 mg oral tablet packaging label displaying the product name and strength prominently. The label includes NDC 72319-015-60, storage instructions, barcode, and manufacturer information for i3 Pharmaceuticals, LLC. The package states "DISPENSE WITH MEDICATION GUIDE ENCLOSED OR PROVIDED SEPARATELY" and that the product is Rx only. Contents mention 6 blister cards of 10 tablets each.*

FDA Label Image

Everolimus-carton-0-75-mg (Everolimus Carton 0 75 mg)

Packaging label for Everolimus Tablets 0.75 mg per tablet by i3 Pharmaceuticals, LLC. The carton includes the NDC number 72319-016-60, states Rx Only, and contains 6 blister cards of 10 tablets each. Storage instructions, side effect reporting information, and a barcode are also visible.*

FDA Label Image

Everolimus-carton-1-mg (Everolimus Carton 1 mg)

Packaging label for Everolimus Tablets 1 mg per tablet by i3 Pharmaceuticals, LLC. The label shows the NDC 72319-017-60 and states "Dispense with medication guide enclosed or provided separately." It includes storage and usage instructions, barcode, and notes that the package contains 6 blister cards of 10 tablets each. The label prominently displays the product name, strength, and manufacturer information.*

FDA Label Image

Everolimus-container-0-25-mg (Everolimus Container 0 25 mg)

Label for Everolimus Tablets 0.25 mg by i3 Pharmaceuticals, LLC. The bottle contains 60 oral tablets, each with 0.25 mg of active ingredient everolimus. The label includes storage instructions, dispensing guidance for pharmacists, and manufacturer information with a barcode and QR code on the right.*

FDA Label Image

Everolimus-container-0-5-mg (Everolimus Container 0 5 mg)

Everolimus Tablets 0.5 mg oral tablet bottle label from i3 Pharmaceuticals, LLC. The container holds 60 tablets. The label includes storage instructions, dosage advisory to consult the package insert, and a barcode with a QR code for tracking. The label warns to protect from light and moisture and keep out of reach of children.*

FDA Label Image

Everolimus-container-0-75-mg (Everolimus Container 0 75 mg)

Everolimus Tablets 0.75 mg oral tablets packaging label. The label states the product contains 0.75 mg of everolimus per tablet and is supplied in a quantity of 60 tablets. It is manufactured and distributed by i3 Pharmaceuticals, LLC, located in Warminster, PA. Additional information includes storage instructions, dosage note, and a barcode with QR code for scanning.*

FDA Label Image

Everolimus-container-1-mg (Everolimus Container 1 mg)

Everolimus Tablets 1 mg oral tablets label from i3 Pharmaceuticals, LLC. The package contains 60 tablets. The label includes storage instructions to keep the product between 20°C to 25°C with permitted excursions, and warnings to protect from light and moisture. The label indicates the product is prescription only and includes contact information for reporting side effects to the FDA.*

FDA Label Image

Figure-1 (Figure 1)

A line graph depicting estimated glomerular filtration rate (eGFR MDRD 4) over various visit windows for two treatment groups: EVR plus reduced TAC and TAC control. The y-axis measures eGFR in mL/min/1.73 m², ranging from 60 to 110, while the x-axis shows visit time points from screening (Sc) through 24 months (M24). Error bars indicate variability at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.